Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02190955 · ClinicalTrials.gov registry record
Assessment of the Educational Experiences for Patients Newly Diagnosed With Nephrotic Syndrome
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 186
- Enrollment target
NCT02190955: Completed study, sponsored by University of South Florida.
NCT02190955 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 186 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02190955 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 186 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about patient, caregiver and healthcare worker perspectives on educating patients with newly-diagnosed Nephrotic Syndrome. All patients enrolled in the Contact Registry with Nephrotic Syndrome will be invited via email to participate in this study.
Primary Outcome
The outcome measure(s) will be evaluated based on the cross-sectional online questionnaire. The questionnaire is the only study procedure for this online patient contact registry protocol and will be the sole analysis tool for both the primary and secondary outcome measures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-05 |
What the finished NCT02190955 record still lists
NCT02190955 is an observational study that tracks outcomes without assigning an intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02190955 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02190955 about?
NCT02190955 is a clinical study titled "Assessment of the Educational Experiences for Patients Newly Diagnosed With Nephrotic Syndrome". The purpose of this study is to learn about patient, caregiver and healthcare worker perspectives on educating patients with newly-diagnosed Nephrotic Syndrome. All patients enrolled in the Contact Registry with Nephrotic Syndrome will be invited via email to participate in this study.
What is the current status of trial NCT02190955?
This trial is currently completed. The enrollment target is 186 participants. The study started on 2013-01. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT02190955?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03567889 · 186 participants · Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- NCT05281471 · 186 participants · Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- NCT05405595 · 186 participants · Phase 1
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- NCT05762107 · 186 participants · Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia